Live Yum Brands Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow EXICURE, INC.

Get SEC filing alerts via email and in your feed for EXICURE, INC.

XCUR

EXICURE, INC.

About EXICURE, INC.

Exicure, Inc. is a biotechnology company focused on developing nucleic acid therapies targeting RNA. It has historically worked on spherical nucleic acid (SNA) technology for therapeutic applications but has shifted to exploring strategic transactions and asset sales. The company owns a patent portfolio, engages in licensing, and seeks growth through acquisitions and partnerships, primarily in Asia, with no current revenue stream or manufacturing operations.
This description was generated via AI from an annual report. Updated 10 months ago.

Latest SEC Filings from EXICURE, INC.

1
1
EXICURE, INC. Exicure Reports $1.8 Million Net Loss in Q1 2026 Amid Restructuring Efforts

Via official filing (AI summary) | about 2 months ago | 0 comments

2
1
EXICURE, INC. Exicure Reports $4.9 Million Net Loss for Fiscal Year 2025, Seeks Strategic Alternatives

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
EXICURE, INC. Exicure Reports Q3 2025 Financial Results with Increased Net Loss and No Revenue

Via official filing (AI summary) | 9 months ago | 0 comments

4
1
EXICURE, INC. Exicure Reports $2.6 Million Net Loss in Q2 2025, No Revenue Generated

Via official filing (AI summary) | 12 months ago | 0 comments

5
1
EXICURE, INC. Exicure Reports $3M Net Income Turnaround Amid Increased Operating Expenses and Acquisition of GPCR USA

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
EXICURE, INC. Exicure Reports $9.7 Million Net Loss for Fiscal Year 2024, Highlights Strategic Changes

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
EXICURE, INC. Exicure Reports Improved Financials, Reduced Losses, and Ongoing Efforts to Secure Additional Financing

Via official filing (AI summary) | over 1 year ago | 0 comments